Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Filippo Pietrantonio

Researcher (non-academic)

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Laura Mazzeo

National Institute of Oncology

ITALY

View details

Davide Citterio

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Clara Montagut Viladot

Head Gastrointestinal Cancer Section

Hospital del Mar

SPAIN

View details

Valeria Pessei

Candiolo Cancer Institute

ITALY

View details

Giulia Martini

University of Campania “Luigi Vanvitelli”

ITALY

View details

Antonio Avallone

Chief of DH Chemotherapy

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Nicola Personeni

Humanitas University

ITALY

View details

Monica Niger

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Daniele Rossini

University of Florence

ITALY

View details

Antonia Martinetti

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Alessandro Cavaliere

ITALY

View details

Matteo Virdis

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Filippo Pietrantonio

Research Interests

Explore related searches

Articles (20)

Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives

Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study

A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis

Anti-EGFR Rechallenge in Patients with Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer A Nonrandomized Controlled Trial

Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion

Controversies in upper GI: liquid biopsies

Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM)

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer

Negative Hyperselection of Patients with HER2<sup>+</sup> and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

New options for late-line treatment of metastatic colorectal cancer

Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials

Treatment of patients with BRAF<sup>V600E</sup>-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset

Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues

Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials

Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials

Collaborators (12)

Laura Mazzeo

Davide Citterio

Clara Montagut Viladot

Valeria Pessei

Giulia Martini

Antonio Avallone

Nicola Personeni

Monica Niger

Daniele Rossini

Antonia Martinetti

Alessandro Cavaliere

Matteo Virdis

Make your next move.